Biologics & Biosimilars

Helping companies capture opportunities across the value chain for biologics and biosimilars, and forging connections among industry stakeholders through certification and training capabilities to help standardize knowledge in this field.

Partnering with the top 250+ pharma, biotech and healthcare organizations

  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda

What we do

We work with companies focused on biologics and biosimilars production such as specialty pharmaceutical companies, specialty pharmacies, wholesalers, pharmacy benefit managers (PBMs), and payers. Our work has covered a wide range of topics, including strategy, operations, marketing, organization, due diligence, and digital capabilities enhancement. We offer AI enabled biologics and biosimilars tools that can help companies prepare for an increasingly competitive market.

individual learning

Building Standards that Last

The ACMA developed the first ever accredited board certification for Biologics and Biosimilars known as the Board Certified Biologics & Biosimilars Specialist (BCBBS) program. This accredited, certification program captures all the key areas any professional working in the biologics and biosimilars space needs to be successful.

  • Format - 100% Online, self paced

  • Time Needed to Complete - 18-20 hours

  • Exam Required - Yes (online)

  • Support Provided - 24/7 Live Chat Included